Login
From:
www.roche.com
(Uncensored)
subscribe
[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on Phase III GRADUATE programme evaluating gantenerumab in early Alzheimer’s disease
https://www.roche.com/media/releases/med-cor-2022-11-14
links
backlinks
Roast topics
Find topics
Find it!
Phase III GRADUATE studies did not meet their primary endpoints of slowing clinical decline in people with early Alzheimer’sThe level of beta-amyloid removal by gantenerumab was lower than expected...
